GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,370
Funds Holding Change
-1
Funds Holding Growth
-0%
Value
$421B
Holding in Top 10
466
Top 10 Change
-74
Top 10 Growth
-14%
Value Growth
-2%
New
100
Increased
1,032
Reduced
1,067
Closed
89
Capital Inflow
$22.4B
Capital Outflow
$20.7B
Net Capital Flow
+$1.75B
Capital Flow Change
+$515M
Calls
$7.83B
Puts
$6.52B
Net Calls
+$1.31B
Put/Call Ratio
0.83